跳至主要内容
临床试验/CTRI/2020/08/027133
CTRI/2020/08/027133已完成未知

Efficacy of olanzapine along with nutritional advice on reducing anorexia in patients undergoing chemotherapy for gastric, hepato-pancreaticobiliary and lung cancer- A double-blinded randomized-controlled trial(CRAOLA) - CRAOLA

Jawaharlal Institute of Postgraduate Medical Education and Reseach0 个研究点目标入组 124 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
124

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • stage 3 or 4 of Gastric Hepatopancreaticobiliary and lung cancer, who are fit for chemotherapy and are able to take oral diet

排除标准

  • a.Patients on adjuvant chemotherapy
  • b.Patients with concurrent radiotherapy
  • c.Intake of olanzapine for more than 4 days per month for any other indications
  • d.On any antipsychotic or antidepressants
  • e.Use of systemic corticosteroids (prednisolone 5mg or equivalent for more than
  • 7 days in the previous 4 weeks)
  • f.Ascites at time of enrolment
  • g.Pregnancy
  • h.Patients already enrolled in other trails within the past 3 months

研究者

发起方
Jawaharlal Institute of Postgraduate Medical Education and Reseach

相似试验